luminol has been researched along with Diabetes Mellitus, Type 2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, C; Li, D; Li, H; Tu, Y | 1 |
| Fan, A; Li, M; Li, S; Zhang, Y | 1 |
| Drábiková, K; Holománová, D; Jancinová, V; Murín, J; Nosál', R; Solík, P | 1 |
| Kashima, K; Mori, M; Ohtani, K; Sato, N; Shimizu, H; Uehara, Y | 1 |
2 trial(s) available for luminol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
On the antioxidant activity of carvedilol in human polymorphonuclear leukocytes in vitro and ex vivo.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Antioxidants; Carbazoles; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Heart Failure; Humans; In Vitro Techniques; Luminescence; Luminol; Male; Middle Aged; Neutrophils; Propanolamines; Reactive Oxygen Species; Tetradecanoylphorbol Acetate | 2006 |
Epalrestat, an aldose reductase inhibitor, improves an impaired generation of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients.
Topics: Aldehyde Reductase; Blood Glucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; In Vitro Techniques; Luminescent Measurements; Luminol; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phagocytosis; Reference Values; Rhodanine; Superoxides; Thiazolidines; Time Factors | 1997 |
2 other study(ies) available for luminol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Fluorescence/electrochemiluminescence approach for instant detection of glycated hemoglobin index.
Topics: Diabetes Mellitus, Type 2; Electrodes; Glycated Hemoglobin; Hematologic Tests; Humans; Luminol | 2022 |
Two-dimensional metal-organic framework catalyzed chemiluminescent reaction for alpha-glucosidase inhibitor screening.
Topics: Acarbose; alpha-Glucosidases; Catalysis; Diabetes Mellitus, Type 2; Glucose; Glycoside Hydrolase Inhibitors; Humans; Hydrogen Peroxide; Limit of Detection; Luminescent Measurements; Luminol; Metal-Organic Frameworks | 2023 |